bat
serum
specimen
n
collect
south
africa
sa
democrat
republ
congo
drc
test
fi
rst
serum
specimen
collect
mpumalanga
limpopo
provinc
sa
studi
rabiesrel
virus
approv
provinci
director
natur
conserv
anim
ethic
committe
univers
witwatersrand
remain
serum
sampl
collect
bandundu
orient
provinc
drc
studi
ebola
marburg
virus
auspic
intern
committe
control
ebola
hemorrhag
fever
kikwit
marburg
hemorrhag
fever
durbawatsa
coordin
world
health
organ
behalf
govern
drc
bat
caught
mist
net
anesthet
exsanguin
cardiac
punctur
serum
specimen
store
analyz
screen
serum
specimen
use
sarscov
elisa
kit
euroimmun
ag
germani
minor
modifi
cation
bat
serum
sampl
test
dilut
horseradish
peroxidaselabel
goat
antibat
immunoglobulin
ig
conjug
bethyl
montgomeri
al
usa
use
secondari
antibodi
dilut
neg
bat
serum
obtain
captivebr
rousettu
aegyptiacu
nation
institut
communic
diseas
sandringham
sa
cutoff
determin
mean
optic
densiti
valu
nm
observ
neg
control
sampl
posit
serum
sampl
retest
titer
determin
evalu
test
specifi
citi
exclud
possibl
crossreact
virus
especi
hcov
seropreval
human
human
serum
specimen
screen
onlin
technic
appendix
avail
includ
patient
acut
respiratori
infect
serum
specimen
serum
specimen
provid
l
van
der
hoek
confi
rmatori
western
blot
wb
done
use
protein
lysat
vero
cell
cultur
american
type
cultur
collect
manassa
va
usa
crl
infect
sarscov
hong
kong
isol
genbank
access
uninfect
vero
cultur
bat
serum
specimen
appli
dilut
secondari
detect
perform
supersign
west
dura
extend
substrat
chemiluminesc
detect
assay
pierc
biotechnolog
rockford
il
usa
signal
intens
spike
nucleocapsid
n
protein
evalu
independ
oper
second
confi
rmatori
wb
recombin
sarscov
protein
use
prokaryot
express
recombin
sarscov
n
protein
fragment
protein
amino
acid
posit
follow
instruct
champion
pet
direct
topo
express
kit
invitrogen
karlsruh
germani
use
plasmid
purifi
cation
refold
protein
column
done
describ
previous
purifi
ed
recombin
protein
resolv
electrophoresi
discontinu
sodium
dodecyl
sulfatepolyacrylamid
gel
blot
nitrocellulos
strip
incub
bat
serum
sampl
dilut
one
posit
bat
serum
specimen
use
refer
exclud
robert
kochinstitut
berlin
germani
institut
communic
diseas
sandringham
south
africa
nocht
institut
tropic
medicin
hamburg
germani
intern
cape
town
south
africa
ag
germani
variat
experiment
procedur
signal
intens
serum
specimen
produc
signal
dilut
consid
posit
none
control
serum
specimen
show
reactiv
dilut
evalu
assay
specifi
citi
test
control
serum
specimen
compris
randomli
select
bat
serum
specimen
neg
elisa
sarscovposit
human
serum
specimen
sarscovneg
human
serum
specimen
includ
serum
specimen
commerci
indirect
immunofl
uoresc
test
sarscoviftii
kit
euroimmun
ag
carri
describ
manufactur
except
bat
serum
sampl
dilut
slide
incub
room
temperatur
hour
reaction
detect
goatantibat
immunogolublin
ig
bethyl
dilut
fl
uorescein
isothiocyanatelabel
donkeyantigoat
ig
dianova
hamburg
germani
dilut
specifi
citi
indirect
immunofl
uoresc
test
iift
determin
screen
human
serum
specimen
sensit
correl
iift
versu
elisa
analyz
onlin
technic
appendix
addit
select
control
serum
sampl
test
viru
neutral
test
perform
describ
elsewher
except
use
vero
cell
cultur
dulbecco
modifi
ed
eagl
medium
sarscov
hong
kong
isol
pfuml
dilut
bat
serum
dilut
quadrupl
rang
incub
co
day
cell
fi
xed
formaldehyd
result
interpret
describ
viral
rna
extract
serum
use
qiaamp
viral
rna
extract
kit
qiagen
hilden
germani
revers
transcriptionpcr
rtpcr
perform
essenti
describ
elsewher
except
avail
everi
bat
case
input
volum
reduc
replac
water
minimum
usual
test
antibodi
activ
sarscov
antigen
detect
elisa
bat
speci
test
collect
site
seropreval
highest
preval
found
fruit
bat
rousettu
aegyptiacu
chiroptera
pteropodida
insectivor
bat
mop
condyluru
chiroptera
molossida
tabl
elisa
titer
rang
serum
sampl
confi
rmatori
wb
analys
perform
method
elisaposit
sampl
suffi
cient
materi
remain
avail
posit
serum
specimen
iift
posit
sampl
tabl
figur
figur
neutral
activ
sarscov
found
elisaposit
sampl
rtpcr
detect
cov
nucleic
acid
serum
specimen
test
data
shown
result
wb
analys
support
specifi
citi
elisa
use
studi
test
known
less
sensit
elisa
still
provid
confi
rmation
one
third
serum
specimen
test
neg
result
viral
neutral
test
unexpect
assay
detect
antibodi
interfer
specifi
c
entri
mechan
sarscov
put
group
cov
african
bat
may
use
moreov
delet
mutat
found
asian
bat
sarslikecov
isol
lie
protein
region
essenti
bind
sarscov
cellular
receptor
angiotensinconvert
enzym
thu
like
affect
crossneutr
emphas
confl
ict
result
obtain
asia
neg
fi
nding
obtain
rtpcr
explain
unlikelihood
fi
nding
viru
nucleic
acid
serum
studi
asia
use
rectal
swab
instead
serum
sampl
viru
like
persist
enter
tract
may
found
serum
bat
speci
r
aegyptiacu
condyluru
wide
distribut
africa
vari
degre
contact
human
r
aegyptiacu
roost
cave
forag
orchard
wherea
condyluru
roost
build
result
preliminari
studi
suggest
neg
bat
serum
specimen
test
use
fulllength
recombin
sarscov
n
fragment
protein
amino
acid
serum
specimen
dilut
left
strip
right
strip
secondari
detect
perform
incub
nitrocellulos
strip
horseradish
peroxidas
hrp
label
goatantibat
immunoglobulin
ig
bethyl
montgomeri
al
usa
chemiluminesc
supersign
dura
substrat
pierc
biotechnolog
rockford
il
usa
ad
fi
lm
expos
min
serum
use
refer
compar
blot
evalu
purpos
strip
also
incub
human
sarscovposit
b
neg
serum
specimen
c
posit
dilut
use
goatantihuman
ig
hrp
secondari
detect
serum
specimen
produc
signal
dilut
record
posit
vero
cell
infect
sever
acut
respiratori
syndromeassoci
coronaviru
sarscov
sarscov
diagnost
iift
kit
euroimmun
ag
germani
use
minor
modifi
cation
bat
refer
human
serum
specimen
dilut
found
optim
dilut
bat
sera
sampl
buffer
secondari
detect
perform
goatantibat
immunoglobulin
ig
bethyl
montgomeri
al
usa
follow
fl
uorescein
isothiocyan
fitc
label
donkeyantigoat
ig
dianova
hamburg
germani
af
fitclabel
goatantihuman
ig
gi
frame
ad
sarscov
elisaposit
bat
serum
specimen
ef
elisaneg
bat
serum
specimen
show
unspecifi
c
signal
gh
sarscovposit
human
control
serum
specimen
b
neg
human
serum
c
photograph
taken
equival
microscop
set
scale
bar
repres
african
bat
speci
harbor
agent
relat
put
group
cov
therefor
investig
undertaken
determin
potenti
public
health
risk
